Abdominal adiposity and daily step counts as determinants of glycemic control in a cohort of patients with type 2 diabetes mellitus

Nutrition and Diabetes

Volumn 2, Issue JANUARY, 2012, Pages

  Manjoo, P ^a,b   Joseph, L ^a   Dasgupta, K ^a  

^a MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

^b VANCOUVER ISLAND HEALTH AUTHORITY   (Canada)

Author keywords

A1C; Epidemiology; Pedometer; Waist circumference; Waist to hip ratio

Indexed keywords

HEMOGLOBIN A1C; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; METFORMIN; ORAL ANTIDIABETIC AGENT; SULFONYLUREA;

ABDOMINAL OBESITY; ADULT; ANTHROPOMETRIC PARAMETERS; ARTICLE; BODY MASS; CLINICAL ASSESSMENT; CROSS-SECTIONAL STUDY; DIASTOLIC BLOOD PRESSURE; FEMALE; GLYCEMIC CONTROL; HEMOGLOBIN BLOOD LEVEL; HIP CIRCUMFERENCE; HUMAN; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PEDOMETER; PRIORITY JOURNAL; SYSTOLIC BLOOD PRESSURE; WAIST CIRCUMFERENCE; WALKING;

EID: 84872411659     PISSN: None     EISSN: 20444052     Source Type: Journal    
DOI: 10.1038/nutd.2011.22     Document Type: Article

References (32)

1. Gallagher D, Kelley DE, Yim JE, Spence N, Albu J, Boxt L et al. Adipose tissue distribution is different in type 2 diabetes. Am J Clin Nutr 2009; 89: 807-814.
2. Zamboni M, Armellini F, Milani MP, De Marchi M, Todesco T, Robbi R et al. Body fat distribution in pre-and post-menopausal women: metabolic and anthropometric variables and their inter-relationships. Int J Obes Relat Metab Disord 1992; 16: 495-504.
3. Sam S, Haffner S, Davidson MH, D'Agostino Sr RB, Feinstein S, Kondos G et al. Hypertriglyceridemic waist phenotype predicts increased visceral fat in subjects with type 2 diabetes. Diabetes Care 2009; 32: 1916-1920.
4. Selvin E, Coresh J, Golden SH, Boland LL, Brancati FL, Steffes MW. Glycemic control, atherosclerosis, and risk factors for cardiovascular disease in individuals with diabetes: the atherosclerosis risk in communities study. Diabetes Care 2005; 28: 1965-1973.
5. Uusitupa MI. Early lifestyle intervention in patients with non-insulin-dependent diabetes mellitus and impaired glucose tolerance. Ann Med 1996; 28: 445-449.
6. Walker KZ, Piers LS, Putt RS, Jones JA, O'Dea K. Effects of regular walking on cardiovascular risk factors and body composition in normoglycemic women and women with type 2 diabetes. Diabetes Care 1999; 22: 555-561.
7. Dasgupta K, Chan C, Da Costa D, Pilote L, De Civita M, Ross N et al. Walking behaviour and glycemic control in type 2 diabetes: seasonal and gender differences-study design and methods. Cardiovasc Diabetol 2007; 6: 1.
8. Manjoo P, Joseph L, Pilote L, Dasgupta K. Sex differences in step count-blood pressure association: a preliminary study in type 2 diabetes. PLoS One 2010; 5: e14086.
9. Cyarto EV, Myers AM, Tudor-Locke C. Pedometer accuracy in nursing home and community-dwelling older adults. Med Sci Sports Exerc 2004; 36: 205-209.
10. Shepherd EF, Toloza E, McClung CD, Schmalzried TP. Step activity monitor: increased accuracy in quantifying ambulatory activity. J Orthop Res 1999; 17: 703-708.
11. Shatenstein B, Nadon S, Godin C, Ferland G. Development and validation of a food frequency questionnaire. Can J Diet Pract Res 2005; 66: 67-75.
12. Schneider PL, Crouter SE, Bassett DR. Pedometer measures of free-living physical activity: comparison of 13 models. Med Sci Sports Exerc 2004; 36: 331-335.
13. Crouter SE, Schneider PL, Karabulut M, Bassett Jr DR. Validity of 10 electronic pedometers for measuring steps, distance, and energy cost. Med Sci Sports Exerc 2003; 35: 1455-1460.
14. Craig CL, Marshall AL, Sjostrom M, Bauman AE, Booth ML, Ainsworth BE et al. International physical activity questionnaire: 12-country reliability and validity. Med Sci Sports Exerc 2003; 35: 1381-1395.
15. Team RDC. A language and environment for statistical computing. R Foundation for Statistical Computing: Vienna, 2007.
16. Tudor-Locke C, Bassett Jr DR. How many steps/day are enough? Preliminary pedometer indices for public health. Sports Med 2004; 34: 1-8.
17. Qin L, Corpeleijn E, Jiang C, Thomas GN, Schooling CM, Zhang W et al. Physical activity, adiposity, and diabetes risk in middle-aged and older Chinese population: the Guangzhou Biobank Cohort Study. Diabetes Care 2010; 33: 2342-2348.
18. Hamaguchi M, Kojima T, Takeda N, Nakagawa T, Taniguchi H, Fujii K et al. The metabolic syndrome as a predictor of nonalcoholic fatty liver disease. Ann Intern Med 2005; 143: 722-728.
19. Hanley AJ, Williams K, Festa A, Wagenknecht LE, D'Agostino Jr RB, Haffner SM. Liver markers and development of the metabolic syndrome: the insulin resistance atherosclerosis study. Diabetes 2005; 54: 3140-3147.
20. Despres JP. The insulin resistance-dyslipidemic syndrome of visceral obesity: effect on patients' risk. Obes Res 1998; 6(Suppl 1): 8S-17S.
21. Despres JP, Lemieux I. Abdominal obesity and metabolic syndrome. Nature 2006; 444: 881-887.
22. Koro CE, Bowlin SJ, Bourgeois N, Fedder DO. Glycemic control from 1988 to 2000 among US adults diagnosed with type 2 diabetes: a preliminary report. Diabetes Care 2004; 27: 17-20.
23. Turner RC, Cull CA, Frighi V, Holman RR. Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: progressive requirement for multiple therapies (UKPDS 49). UK Prospective Diabetes Study (UKPDS) Group. JAMA 1999; 281: 2005-2012.
24. UK prospective diabetes study 16. Overview of 6 years' therapy of type II diabetes: a progressive disease. UK Prospective Diabetes Study Group. Diabetes 1995; 44: 1249-1258.
25. Thomas DE, Elliott EJ, Naughton GA. Exercise for type 2 diabetes mellitus. Cochrane Database Syst Rev 2006; 3: CD002968.
26. Cuff DJ, Meneilly GS, Martin A, Ignaszewski A, Tildesley HD, Frohlich JJ. Effective exercise modality to reduce insulin resistance in women with type 2 diabetes. Diabetes Care 2003; 26: 2977-2982.
27. Mourier A, Gautier JF, De Kerviler E, Bigard AX, Villette JM, Garnier JP et al. Mobilization of visceral adipose tissue related to the improvement in insulin sensitivity in response to physical training in NIDDM. Effects of branched-chain amino acid supplements. Diabetes Care 1997; 20: 385-391.
28. Minuk HL, Vranic M, Marliss EB, Hanna AK, Albisser AM, Zinman B. Glucoregulatory and metabolic response to exercise in obese noninsulin-dependent diabetes. Am J Physiol 1981; 240: E458-E464.
29. Devlin JT, Hirshman M, Horton ED, Horton ES. Enhanced peripheral and splanchnic insulin sensitivity in NIDDM men after single bout of exercise. Diabetes 1987; 36: 434-439.
30. Koivisto VA, Pelkonen R, Nikkila EA, Heding LG. Human and porcine insulins are equally effective in the regulation of glucose kinetics of diabetic patients during exercise. Acta Endocrinol (Copenh) 1984; 107: 500-505.
31. Crouter SE, Schneider PL, Bassett Jr DR. Spring-levered versus piezo-electric pedometer accuracy in overweight and obese adults. Med Sci Sports Exerc 2005; 37: 1673-1679.
32. Tyo BM, Fitzhugh EC, Bassett Jr DR, John D, Feito Y, Thompson DL. Effects of body mass index and step rate on pedometer error in a free-living environment. Med Sci Sports Exerc 2011; 43: 350-356.